{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:06:56Z","timestamp":1791893216179,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.111276","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:51Z","timestamp":1761930051000},"page":"111276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Safety of contraception among women using anticoagulant therapy: An updated systematic review"],"prefix":"10.1016","volume":"159","author":[{"given":"Antoinette T.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111276_bib1","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.contraception.2025.111276_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jtha.2024.12.003","article-title":"New targets for antithrombotic medications: seeking to decouple thrombosis from hemostasis","volume":"23","author":"Barnes","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.111276_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/bloodadvances.2024015371","article-title":"Duration of primary\/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.contraception.2025.111276_bib4","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111276_bib5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.111276_bib6","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s11606-022-07528-y","article-title":"Special considerations for women of reproductive age on anticoagulation","volume":"37","author":"Azenkot","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.contraception.2025.111276_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111276_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111276_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib10","article-title":"Safety of hormonal contraception among women on anticoagulant therapy: a systematic review","author":"Nguyen","year":"2022","journal-title":"PROSPERO"},{"key":"10.1016\/j.contraception.2025.111276_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111276_bib12","unstructured":"Veritas Health Innovation. Covidence systematic review software. Available from: \u3008https:\/\/www.covidence.org\/\u3009 (accessed October 9, 2025)."},{"key":"10.1016\/j.contraception.2025.111276_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 63","article-title":"Chapter 25: Assessing risk of bias in a non-randomized study","author":"Sterne","year":"2022"},{"key":"10.1016\/j.contraception.2025.111276_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2016.07.011","article-title":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib15","unstructured":"GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. 2022. Available from: \u3008https:\/\/www.gradepro.org\/\u3009 (accessed October 9, 2025)."},{"key":"10.1016\/j.contraception.2025.111276_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111276_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111276_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0010-7824(92)90143-H","article-title":"Contraception after heart surgery","volume":"45","author":"Abdalla","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2018.07.139","article-title":"Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception","volume":"98","author":"Bernard","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2013.06.012","article-title":"Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and\/or a history of thrombosis","volume":"89","author":"Braga","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijgo.13378","article-title":"Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy","volume":"151","author":"Brull","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2025.111276_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/bmj.2.6200.1260","article-title":"Interaction between anticoagulants and contraceptives: an unsuspected finding","volume":"2","author":"de Teresa","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.111276_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0026-0495(76)90044-5","article-title":"Heparin metabolism and heparin-release lipase activity during long-term estrogen-progestin treatment","volume":"25","author":"Ence","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2025.111276_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2009.02.007","article-title":"The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement","volume":"80","author":"Kilic","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111276_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2007.07.1315","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders","volume":"90","author":"Lukes","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2025.111276_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jadohealth.2022.02.009","article-title":"Management of contraception in adolescent females with hormone-related venous thromboembolism","volume":"71","author":"Maher","year":"2022","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2025.111276_bib27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111276_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mayocpiqo.2021.12.005","article-title":"Bleeding complications associated with intrauterine contraception in women receiving anticoagulation therapy","volume":"6","author":"O'Laughlin","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.contraception.2025.111276_bib29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.contraception.2025.111276_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13625180400020952","article-title":"Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum","volume":"10","author":"Sonmezer","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111276_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmig.2009.04.018","article-title":"The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy","volume":"16","author":"Vilos","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.contraception.2025.111276_bib32","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/bmj.321.7273.1382","article-title":"Drug points: apparent interaction between warfarin and levonorgestrel used for emergency contraception","volume":"321","author":"Ellison","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111276_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/0091270005280851","article-title":"Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail","volume":"45","author":"Shelepova","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2025.111276_bib34","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2025.111276_bib35","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajog.2005.05.002","article-title":"The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders","volume":"193","author":"Schaedel","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111276_bib36","unstructured":"Centers for Disease Control and Prevention. Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Available from: \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156516\u3009 (accessed October 9, 2025)."},{"key":"10.1016\/j.contraception.2025.111276_bib37","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.111276_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.contraception.2025.111276_bib39","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jcph.1285","article-title":"FDA Public Meeting Report on \"Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications\"","volume":"58","author":"Akbar","year":"2018","journal-title":"J Clin Pharmacol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425004676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425004676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:17:59Z","timestamp":1780712279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425004676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S0010782425004676"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111276","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of contraception among women using anticoagulant therapy: An updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111276"}}